Ostarine will be the closest SARM to remaining permitted in drugs and it is at the moment in period II scientific trials. Like SARMs generally speaking, MK-2866 targets androgen receptors on a selective basis and avoids building the kinds of damaging side effects affiliated with substances like testosterone, human growth https://aristotlei543xoe1.wikigdia.com/user